We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat... Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke. Show more
Ask ADVFN Intelligence (AI)
REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating ResultsFDA approval on track for first quarter 2025, U.S. commercial team build out in progressCompany fully funded with...
Nyxoah Appoints John Landry as Chief Financial Officer Current CFO, Loïc Moreau, to Transition into Role of President International Mont-Saint-Guibert, Belgium – November 4, 2024, 10:45pm CET /...
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 25, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 14...
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 Mont-Saint-Guibert, Belgium – October 22, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH...
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 15, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.15 | -12.0041753653 | 9.58 | 9.9 | 8.1 | 39105 | 9.12274249 | CS |
| 4 | -0.92 | -9.83957219251 | 9.35 | 10.01 | 8.1 | 26253 | 9.51083176 | CS |
| 12 | 0.03 | 0.357142857143 | 8.4 | 10.12 | 7.28 | 70027 | 9.26535346 | CS |
| 26 | -0.29 | -3.32568807339 | 8.72 | 12.21 | 6.76 | 47588 | 9.06244581 | CS |
| 52 | 3.07 | 57.276119403 | 5.36 | 20 | 4 | 45217 | 9.81173313 | CS |
| 156 | -15.21 | -64.3401015228 | 23.64 | 24.275 | 4 | 22302 | 9.27717481 | CS |
| 260 | -21.59 | -71.9187208528 | 30.02 | 37 | 4 | 21492 | 11.00497327 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
